9 enregistrements totalisant 5,525,571.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
| Instituts de recherche en santé du Canada | $5,525,571 | 9 enregistrements |
Aldosterone antagonism and enhanced Clearance for Health Improvement EValuation in End-stage renal disease (ACHIEVE) Trial
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: extended follow-up of a randomized controlled trial
Improving patient important outcomes for hemodialysis patients using pharmacological and dialysis-based strategies
Remote Ischemic Preconditioning in Cardiac Surgery Trial (Remote IMPACT)
Protection of the heart with aldosterone antagonism in end-stage renal disease (PHASE 2) Trial
Protection of the heart with aldosterone antagonism in end-stage renal disease (PHASE 2) Trial
Pilot trial of Hemodialysis patients undergoing Aldosterone antagoniSm with Eplerenone (PHASE)